# Edale Capital

> Edale Capital is a VC fund in Sydney backing Health Care, Biotechnology and Medical. See 2 investments, check sizes, portfolio. Updated Sep 2026.

- Type: VC Fund
- Location: Sydney, Australia
- Total investments: 2
- Last investment: Aug 2026
- Lead investor: 0%
- Last updated: Sep 2026
- LinkedIn: https://www.linkedin.com/company/edalecapital/about/

Edale Capital is an investment firm.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 100% |
| Biotechnology | 2 | 100% |
| Medical | 1 | 50% |
| Software | 1 | 50% |
| Wearables | 1 | 50% |

10 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 50% |
| Pre-Seed | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| bowerlabs.ai | Bower develops software and wearable hardware for documenting and supporting scientific laboratory work. Its Bower Workspace combines capture and record functions for collecting voice notes, images, videos, text, configurations, and experimental data. The platform organizes these inputs into searchable records for laboratory teams. Bird is anintegrated AI assistant that uses workspace notes and web-based scientific information to answer questions, summarize findings, compare experiments, and provide citations. Bower Smart Glasses provide hands-free procedure guidance and documentation support at the laboratory bench. The products support research documentation, collaboration, protocol execution, and transfer of technical knowledge. | $1.4M | Pre-Seed | Aug 19, 2026 | https://bowerlabs.ai |
| Proseek Bio | Proseek Bio is a clinical diagnostics company specialising in women’s health, specifically focusing on the early detection of ovarian cancer. | $1M | Seed | Apr 01, 2026 | https://www.proseek.bio/ |

2 of 2 investments shown.

## Co-investors
- [Admiralty Capital Group](https://shizune.co/investors/profile/admiralty-capital-group) — VC Fund, 1 deal together
- [Angelloop](https://shizune.co/investors/profile/angelloop) — VC Fund, 1 deal together
- AusHealth — VC Fund, 1 deal together
- [Scale Investors](https://shizune.co/investors/profile/scale-investors) — VC Fund, 1 deal together
- [TEN13](https://shizune.co/investors/profile/ten13) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Edale Capital invest in?

Edale Capital invests primarily in Health Care, Biotechnology and Medical startups, most often at Seed and Pre-Seed stage. Most of the 2 investments tracked by Shizune back companies in Australia. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Edale Capital last invest?

The most recent investment recorded for Edale Capital closed in Aug 2026. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co